Loading

Boehringer Ingelheim Animal Health

June 16, 2025
Company Presentation
Multiline Global Biopharma
Boehringer Ingelheim is an independent company and a global leader in both animal and human health. We focus on delivering breakthrough innovation - wherever it originates - to tackle the most important scientific challenges we face. That's why we're one of the industry's leading investors in animal health innovation. We're always looking to the future: staying ahead of the science and embracing disruptive technology; analyzing current and future trends to anticipate potential impacts on animal health and connecting with global experts to be at the forefront of knowledge on emerging and transboundary diseases. Our partners are central to this. But we can’t rest until we’ve met every challenge, addressed every unmet need, and answered every scientific question. So, let's work together to pursue science and solutions and build a healthier future for animals.
Boehringer Ingelheim Animal Health
Company HQ City: Binger Strasse 173 Ingelheim am Rhein
Company HQ State: Rhineland-Palatinate
Company HQ Country: Germany
Year Founded: 1885
Lead Product in Development: Multiple products in development

CEO

Hubertus von Baumbach, Chairman of the Board of Managing Directors

Year Founded

1885

Development Phase of Lead Product

Multiple Products in Market

Website

https://www.boehringer-ingelheim.com/partnering/animal-health-partnering
Primary Speaker
Megan Grether
Megan Grether, PhD
Head of Global Business Development & Licensing, Animal Health
Boehringer Ingelheim International GmbH

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS